BSE Live
Jan 01, 16:01Prev. Close
73.25
Open Price
72.11
Bid Price (Qty.)
72.30 (1)
Offer Price (Qty.)
76.49 (50)
NSE Live
Jan 01, 15:41Prev. Close
73.32
Open Price
71.50
Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Bal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 5.14 | 9.05 | 4.75 | 9.18 | 4.10 | |
| Net CashFlow From Operating Activities | 20.32 | 22.81 | -1.84 | 27.71 | 21.78 | |
| Net Cash Used In Investing Activities | -14.92 | -18.89 | -22.18 | -9.48 | -4.98 | |
| Net Cash Used From Financing Activities | -7.84 | -1.21 | 24.40 | -18.13 | -16.63 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -2.44 | 2.71 | 0.37 | 0.09 | 0.16 | |
| Cash And Cash Equivalents Begin of Year | 4.20 | 1.49 | 1.11 | 1.02 | 0.86 | |
| Cash And Cash Equivalents End Of Year | 1.75 | 4.20 | 1.49 | 1.11 | 1.02 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y